CD16/CD32 Monoclonal Antibody (93), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0460479-V3
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $447.00
About this award
The University of Virginia awarded contract A207_PO-0460479-V3 to Life Technologies Corporation effective August 1, 2026, with a total cumulative value of $447. The contract encompasses the procurement of CD16/CD32 Monoclonal Antibody products manufactured by eBioscience, with delivery to the buyer. The line item specifies a quantity of 447 units at a unit price of $1 per item.
Life Technologies Corporation serves as the prime contractor for this Virginia-based procurement. The contract represents a targeted acquisition of laboratory reagents for use by the University of Virginia, with performance occurring within the Commonwealth of Virginia. The modest contract value reflects a small-scale procurement of specialized immunological research materials required for the contracting organization's operations.
Line items
| Item | Total |
|---|---|
| CD16/CD32 Monoclonal Antibody (93), eBioscience | $447.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0460479-V3?
Contract A207_PO-0460479-V3 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 1, 2026.
How much is contract A207_PO-0460479-V3 worth?
Its cumulative value is $447.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award